arcoris bio
1 known investors
Find your way into arcoris bio
368 people in our graph share verified history with the arcoris bio team — schools, employers, funds. One of them is your warm intro.
Christoph Freiunlockedknows Simon Restrepo · together at University of Geneva (overlapped)
knows the team · via ETH Zürich
×4knows the team · via University of Zurich
knows the team · via KTH Royal Institute of Technology
knows the team · via Université Louis Pasteur (Strasbourg I)
×3knows the team · via University of Geneva
Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics. The company's MUSE technology enables precise, sensitive detection of multiple biomarkers across fields including cancer, immunology, neuroscience, and pharmaceutical research.
Founders & leadership
SR
Simon RestrepoinSimon Restrepo is co-founder of Arcoris Bio, which develops multiplex biomarker detection technology using nanotechnology and signal amplification for biomedical research and diagnostics applications.
KB
Kaspar BinzinKaspar Binz is an engineer with over 20 years of experience in biologics and biotech company development. He is co-founder and CEO of Arcoris Bio, which develops multiplex biomarker detection technology for biomedical research and diagnostics.
SF
Scott FraserinScott Fraser holds a B.S. in physics from Harvey Mudd College and a Ph.D. in biophysics from Johns Hopkins University. He has spent his career in academic research and leadership roles, including positions at UC Irvine, Caltech, and USC, with expertise in imaging, molecular analysis, and early-stage biological systems, and he now leads Arcoris Bio, which develops multiplex biomarker detection technology for biomedical research and diagnostics.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeed FundingNov 2025 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does arcoris bio do?
- Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics. The company's MUSE technology enables precise, sensitive detection of multiple biomarkers across fields including cancer, immunology, neuroscience, and pharmaceutical research.
- Who founded arcoris bio?
- arcoris bio was founded by Simon Restrepo, Kaspar Binz, Scott Fraser.
- Who are arcoris bio's investors?
- arcoris bio's investors include Ventura BioMed Investors.